Immune inflammation modulation

Immune inflammation modulation is not a specific molecular target, such as a receptor or enzyme, but rather a complex biological process and therapeutic objective aimed at regulating the immune system's response to internal or external stimuli. It involves the coordinated activity of various immune cell subsets—including T-cells, B-cells, and macrophages—and the signaling molecules they produce, such as cytokines and chemokines (Nature Reviews Immunology, 2021). In a healthy state, this process maintains homeostasis and resolves acute inflammation; however, its dysregulation is a hallmark of chronic conditions like rheumatoid arthritis, inflammatory bowel disease, and asthma (StatPearls, 2023). Therapeutic intervention in this area seeks to either suppress overactive responses in autoimmune diseases or enhance immune activity in the context of oncology (NCI Dictionary, 2024). Because it encompasses an array of pathways including the NF-κB, JAK-STAT, and inflammasome cascades, it cannot be localized to a single gene product or protein structure (Frontiers in Immunology, 2022). Consequently, while 'Immune inflammation modulation' describes a vital area of drug development, it is classified as a physiological category rather than a discrete pharmacological target.

Other names

ImmunomodulationAnti-inflammatory modulationImmune regulationInflammatory response modulation

Not applicable; this is a broad physiological process or therapeutic goal involving the orchestration of various immune cells and signaling pathways rather than a single molecular mechanism of action.